AZD7442 – a potential combination therapy for the prevention and treatment of COVID-19

Trial Identifier: D8850C00001
Sponsor: AstraZeneca
Parexel International
NCTID:: NCT04507256
Start Date: August 2020
Primary Completion Date: October 2021
Condition: COVID-19 Immunisation

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English version

Trial Locations

Country Location
United Kingdom Harrow, United Kingdom, HA1 3UJ